Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 7 | |
Outperform | 13 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 21 analysts offering 12 month price targets for Ultragenyx Pharmaceutical Inc have a median target of 83.00, with a high estimate of 140.00 and a low estimate of 48.00. The median estimate represents a 80.36% increase from the last price of 46.02.
High | 204.2% | 140.00 |
Med | 80.4% | 83.00 |
Low | 4.3% | 48.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 13, 2025.
Average growth rate | +7.83% |
Average growth rate | -23.48% |
More ▼
Revenue history & estimates in USD
Average growth rate | +11.33% |
Average growth rate | +53.47% |
More ▼